Literature DB >> 565077

A clinical evaluation of a test for antibody-coated bacteria in the urine.

U Forsum, A Fritjofsson, L Frödin, E Hjelm, G Jonsell.   

Abstract

A test for antidoby-coated bacteria in the urine for the diagnosis of the anatomical level of urinary tract infection was evaluated in an unselected series of patients with urinary tract infection as a complication of other diseases of the uro-genital tract. Of 19 patients with cancer of the bladder, prostata and the kidney who had clinical signs of lower tract infection, 14 had antibody-coated bacteria in the urine. Among adult patients without cancer of the urinary tract but a clearcut history of upper tract infection, 17 had antibody-coated bacteria, while 8 had not. Six patients also without history of cancer, with clearcut lower tract infection, had antibody-coated bacteria; 38 had not. The results indicate that cancer of the urinary tract seems to influence the correct establishing of level of infection by this method. In patients with diseases of the urinary tract in additional to infection, antibody coating by bacteria in the urine must be interpreted with caution.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 565077

Source DB:  PubMed          Journal:  Scand J Urol Nephrol        ISSN: 0036-5599


  3 in total

1.  Significance of urinary immunoglobulins in tests for antibody-coated bacteria.

Authors:  E Hjelm; U Forsum; L Frödin
Journal:  J Clin Pathol       Date:  1979-12       Impact factor: 3.411

2.  Correlation between uropathogenic properties of Escherichia coli from urinary tract infections and the antibody-coated bacteria test and comparison with faecal strains.

Authors:  H J Brooks; B A Benseman; J Peck; K A Bettelheim
Journal:  J Hyg (Lond)       Date:  1981-08

3.  Virulence of Escherichia coli in acute pyelonephritis, acute cystitis and asymptomatic bacteriuria.

Authors:  J F van den Bosch; P L Oe; P Postma; J de Graaff; D M MacLaren; W H Jansen; P A Guinée
Journal:  Antonie Van Leeuwenhoek       Date:  1980       Impact factor: 2.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.